Stocktoria

SPRUCE BIOSCIENCES, INC. SPRB

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-10-09

SPRUCE BIOSCIENCES, INC. statistics & valuation

Market cap$151.7M
P / B3.6×
Return on equity-91.7%
Net cash$48.9M
Enterprise value USD$102.8M
Earnings yield EBIT/EV-35.5%
Return on capital-85%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2019202020212022202320242025
Operating margin (%)
-515.30% -1143.40% 2019202020212022202320242025
Return on equity (%)
-19.80% -38.00% -67.40% -62.60% -184.00% -91.70% 2019202020212022202320242025
Shares outstanding
764408 23.3M 23.5M 23.6M 41.0M 563042 1.4M 2019202020212022202320242025
Net debt ($)
-$731000 -$152.7M -$37.9M -$18.8M -$92.6M -$36.9M -$48.9M 2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-278.90% -18.10% -33.40% -53.90% -46.10% -117.30% -73.50% 2019202020212022202320242025
Free cash flow margin (%)
330.00% 1140.30% 2019202020212022202320242025
Debt / equity (×)
0.03× 0.04× 0.08× 0.05× 0.06× 0.00× 2019202020212022202320242025
EPS ($)
-$1.81 -$1.96 -$1.24 -$96.40 -$50.83 2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin—-1143.4%-515.3%————
Net margin—-1079.9%-475.0%————
FCF margin—1140.3%330.0%————
Return on assets-73.5%-117.3%-46.1%-53.9%-33.4%-18.1%-278.9%
Return on equity-91.7%-184.0%-62.6%-67.4%-38.0%-19.8%42.7%
Debt / equity0.00×0.06×0.05×0.08×0.04×0.03×-0.10×
Current ratio5.172.904.186.7210.3616.431.08

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.